| Literature DB >> 31740703 |
Yu-Jie Liang1,2, Pan Wang2, Hui-Ping Wang2, Ding-Xin Long2, Ying-Jian Sun3, Yi-Jun Wu4.
Abstract
As a major kind of carbamate insecticide, propoxur plays an important role in agriculture, veterinary medicine, and public health. The acute toxicity of propoxur is mainly neurotoxicity due to the inhibition of cholinesterase. However, little is known regarding the toxicity of propoxur upon long-term exposure at low dose. In this study, Wistar rats were orally administrated with low dose (4.25 mg/kg body weight/day) for consecutive 90 days. And the urine samples in rats treated with propoxur for 30, 60, and 90 days were collected and analyzed by employing 1H NMR-based metabolomics approach. We found that propoxur caused significant changes in the urine metabolites, including taurine, creatinine, citrate, succinate, dimethylamine, and trimethylamine-N-oxide. And the alteration of the metabolites was getting more difference compared with that of the control as the exposure time extending. The present study not only indicated that the changed metabolites could be used as biomarkers of propoxur-induced toxicity but also suggested that the time-course alteration of the urine metabolomic profiles could reflect the progressive development of the toxicity following propoxur exposure.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31740703 PMCID: PMC6861282 DOI: 10.1038/s41598-019-52787-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Change of the rat body weight following exposure to propoxur. The adult rats were orally dosed daily with propoxur (4.25 mg/kg body weight/day) for consecutive 90 days and the body weight of each rat was recorded daily. Data were expressed as mean ± SE with n = 5. *P < 0.05, compared with the control at the same time point.
Organ coefficients of rats after 90-day exposure of propoxur.
| Relative organ weights | Dose level (mg/kg body weight/day) | |
|---|---|---|
| 0 | 4.25 | |
| Terminal body weight (g) | 479.7 ± 13.3 | 439.7 ± 8.1* |
| Brain (g%) | 0.437 ± 0.027 | 0.481 ± 0.017 |
| Heart (g%) | 0.275 ± 0.010 | 0.271 ± 0.026 |
| Liver (g%) | 2.94 ± 0.17 | 2.33 ± 0.09** |
| Spleen (g%) | 0.202 ± 0.021 | 0.199 ± 0.027 |
| Kidneys (g%) | 0.667 ± 0.073 | 0.668 ± 0.064 |
| Testis (g%) | 0.861 ± 0.062 | 0.894 ± 0.048 |
| Adrenals (mg%) | 16.2 ± 3.7 | 15.7 ± 1.5 |
Note: *P < 0.05 and ** P < 0.01, n = 5, compared with the control (0 mg/kg body weight/day).
Serum biochemical parameters of rats after 90-day exposure of propoxur.
| Parameters | Control | Propoxur |
|---|---|---|
| ChE (U/L) | 350.75 ± 56.80 | 230.5 ± 49.44* |
| Cr (mg/dL) | 45.00 ± 4.42 | 43.25 ± 4.79 |
| BUN (mg/dL) | 6.57 ± 1.51 | 6.65 ± 1.13 |
Note: *P < 0.05, n = 5, compared with the control group. Abbreviations: ChE, cholinesterase; Cr, creatinine; BUN, blood urea nitrogen.
Figure 2Photomicrographs of representative sections of the liver and kidneys of rats. Control rats demonstrate normal structure of hepatocytes (A) and nephridial tissue (C). Rats treated with propoxur (4.25 mg/kg body weight/day) for 90 consecutive days exhibited prominent swollen hyperchromatic nuclei (B) and a normal kidney histological structure (D). Scale bar: 50 μm.
Figure 3Principal component analysis (PCA) based on urine 1H NMR spectra obtained from control rats and propoxur-treated rats (4.25 mg/kg body weight/day for 90 days) at four time points including 0 day. (A) PCA score plot (PC1/PC2) for all samples. (B) PCA loading plot revealing the spectral regions (variables) responsible for the discrimination. Key: control group - 0 day (⚪), 30 days (△), 60 days (□), and 90 days (◊); propoxur group - 0 day (●), 30 days (▲), 60 days (■), and 90 days (♦).
Figure 4600 MHz 1H NMR spectra (δ 0.5–9.5) of urine in rats treated with propoxur (4.25 mg/kg body weight/day) for 0 day (a), 30 days (b), 60 days (c), and 90 days (d). Abbreviations: 2-OG, 2-oxoglutarate; DMA, dimethylamine; DMG, dimethylglycine; PAG, phenylacetylglutamine; TMAO, trimethylamine-N-oxide.
Summary of the changes of urine metabolites induced by propoxur.
| Main metabolites | Chemical shifts (ppm) | Days after initial dosing | ||
|---|---|---|---|---|
| 30 | 60 | 90 | ||
| Taurine | 3.26 (t) | = | ↑ | ↑↑** |
| Creatinine | 3.06 (s), 4.06 (s) | = | ↑* | ↑↑* |
| Citrate | 2.54 (d), 2.66 (d) | ↓ | ↓ | ↓↓* |
| 2-OG | 2.46 (t), 3.02 (t) | ↓* | ↓* | ↓↓** |
| Succinate | 2.42 (s) | ↓ | ↓* | ↓↓** |
| PAG | 3.76 (m) | = | ↓ | ↓↓* |
| DMG | 2.94 (s) | = | ↑ | ↑↑** |
| TMAO | 3.27 (s) | = | ↑ | ↑↑* |
| DMA | 2.73 (s) | = | = | ↑ |
| Acetate | 1.92 (s) | ↓ | ↓* | ↓↓** |
Note: The rats were treated daily with propoxur (4.25 mg/kg body weight/day) for 90 consecutive days. Metabolite changes relative to controls are indicated by ↑, ↑↑, ↓, ↓↓, or = , which represents an increase, a further increase, a reduction, a further reduction, or no change, in metabolites, respectively. Keys: d, doublet; m: complex multiplet; s, singlet; t, triplet. Abbreviations: 2-OG, 2-oxoglutarate; TMAO, trimethylamine-N-oxide; DMA, dimethylamine; DMG, dimethylglycine; PAG, phenylacetylglutamine. *P < 0.05 and **P < 0.01, compared with the controls (n = 5).